Investigational drugs in phase I and phase II clinical trials for hereditary angioedema.

about

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema.

Item

http://www.wikidata.org/entity/Q49954636

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema.

@en

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema.

@nl

type

Item

label

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema.

@en

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema.

@nl

prefLabel

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema.

@en

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema.

@nl

P1476

Investigational drugs in phase I and phase II clinical trials for hereditary angioedema.

@en

P2093

Kinga Viktória Kőhalmi

http://www.w3.org/2001/XMLSchema#string

Márta Lídia Debreczeni

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody

HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.

Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P.

Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.

Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities.

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.

HAE international home therapy consensus document.

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

P304

87-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/13543784.2018.1415325

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Henriette Farkas

P577

2017-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29226721

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

phase II clinical trial